About REKOVAR INC.
Rekovar is a startup company founded in late 2020, focused on transforming neonatal care through AI-driven, continuous monitoring technology for Neonatal Abstinence Syndrome (NAS). The company is funded by the NIH - National Institute on Drug Abuse and is developing a patent-pending wearable device to provide real-time insights into neonatal vital signs and symptoms.
AI-driven, continuous monitoring of neonatesIntegration of audio, visual, and physiological dataReal-time insights into vital signs and symptoms of NASAutomated assessment of neonates and medication dosage deliveryDevelopment of wearable, patent-pending technology
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to REKOVAR INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.